Pure Global AI
NCT06262932Not yet recruiting

Effectiveness of Repeated Amiodarone Dosing Regimen Versus Standard Dosing Regimen in Atrial Fibrillation Patient With Rapid Ventricular Response

Police General Hospital, ThailandPhase 4ClinicalTrials.govdrug
Verified
Study focus
Disease/Condition
Atrial Fibrillation
Drug/Device/Intervention
Amiodarone
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Police General Hospital, Thailand
Timeline & enrollment
Phase
Phase 4
Start date
Mar 01, 2024
End date
Dec 31, 2024
Enrollment
32 participants
Primary outcome

Heart rate

Summary

The goal of this clinical trial is to compare in atrial fibrillation patient with rapid
 ventricular response. The main question it aims to answer are Effectiveness of Repeated
 Amiodarone dosing regimen versus standard dosing regimen in Atrial fibrillation patient with
 rapid ventricular response Participants will receive Amiodarone iv treatment with different
 regimen
 
 - Repeated dosing regimen
 
 - Standard dosing regimen

ICD-10 classifications
Chronic atrial fibrillationPersistent atrial fibrillationParoxysmal atrial fibrillationAtrial fibrillation and flutterAtrial fibrillation and atrial flutter, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06262932
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06262932 through Pure Global AI's free database. This Phase 4 trial is sponsored by Police General Hospital, Thailand and is currently Not yet recruiting. The study focuses on Atrial Fibrillation. Target enrollment is 32 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.